Milnacipran (or SAVELLA, IXEL®) is mainly prescribed to treat fibromyalgia.
Class: Serotonin-norepinephrine reuptake inhibitor (SNRI)
FDA Approval: 2008
Dosage Forms: 12.5 mg, 25 mg, 50 mg, 100 mg
Biological Half-life: 8 hours
Side Effects: Dizziness, dry mouth, nausea, headache, constipation, insomnia, hot flush, hyperhidrosis, vomiting, tachycardia, hypertension, sexual dysfunction, increased suicide risk
Routes of Administration: Oral
Pregnancy Category: C (US)